2007 Annual Meeting | Autoimmune Antibody Testing in Neuropathy: Indications for the Practicing Clinician
| 05:45 PM - 08:00 PM |
Reception
|
|
| 06:00 PM - 06:40 PM |
General Principles of Antibody Interpretation and Clinical Correlations
Alan Pestronk, MD, FAAN |
|
| 06:40 PM - 07:20 PM |
Anti-GM1 and GalNAc-GD1a Antibodies
John T. Kissel, MD, FAAN |
|
| 07:20 PM - 08:00 PM |
Anti-MAG, Hu, and Ganglionic Nicotinic Antibodies
Kenneth C. Gorson, MD |
| Kenneth C. Gorson, MD | Dr. Gorson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Gorson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Gorson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Gorson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. |
| John T. Kissel, MD, FAAN | Dr. Kissel has nothing to disclose. |
| Alan Pestronk, MD, FAAN | The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext. |